Our professionals

Dr. Felipe Villacampa

Specialist in Urology.
Primary focus on Uro-oncology, especially tumors of the bladder, kidney, and testicle. Male fertility.

Works at: Madrid headquarters

Be part of: Clínica Universidad de Navarra Cancer Center Clínica Universidad de Navarra

INDEX H 11

Degree in Medicine and Surgery from the Autonomous University of Madrid School of Medicine (1995).

Specialist in Urology from the Complutense University of Madrid (2001) at Hospital 12 de Octubre.

Attending Urologist at Hospital 12 de Octubre in Madrid (2004–2017).

Head of the Uro-oncology Unit of the Department of Urology at Hospital Universitario 12 de Octubre in Madrid until December 2017.

Bladder cancer: projects on the classification of non–muscle-invasive tumors, as well as the study of response to BCG and possible alternatives such as chemo-hyperthermia.
Muscle-invasive bladder cancer: development of trimodal therapy, as well as adjuvant drugs to radical cystectomy.
Renal cancer: study of prognostic factors in localized tumors, as well as the development of ablative therapies together with partial nephrectomy.

Management of bladder, germ cell, and renal cancer, with a clear focus on the patient, research, and teaching.
Since 2012, close collaboration with the Oncogenomics Unit led by Dr. Jesús Paramio (CIEMAT, I+12), creating a prospective biobank in addition to multiple trials in urologic tumors. Currently working on the development of a joint unit with CIMA (Centro de Investigación Médica Aplicada) in Pamplona.
Routine urologic surgeries, with special emphasis on laparoscopic and robotic urology (nephrectomies, partial nephrectomies, adrenalectomies, and radical cystectomies) and organ-sparing therapies.

Teaching professor of clinical practicums at the School of Medicine of the Complutense University of Madrid (2005–2017).

Resident tutor in the Department of Urology at Hospital Universitario 12 de Octubre in Madrid (2011–2017).

Author or co-author of more than 60 articles in national and international journals.

Author or co-author of more than 150 presentations at National and International Urology Congresses.

Principal investigator of 4 research projects and co-investigator in another 10.

Speaker at multiple conference sessions and talks in the specialty, mainly on bladder and renal cancer.